Player FM - Internet Radio Done Right
Checked 16h ago
Menambahkan three tahun yang lalu
Konten disediakan oleh touchpodcast. Semua konten podcast termasuk episode, grafik, dan deskripsi podcast diunggah dan disediakan langsung oleh touchpodcast atau mitra platform podcast mereka. Jika Anda yakin seseorang menggunakan karya berhak cipta Anda tanpa izin, Anda dapat mengikuti proses yang diuraikan di sini https://id.player.fm/legal.
Player FM - Aplikasi Podcast
Offline dengan aplikasi Player FM !
Offline dengan aplikasi Player FM !
Podcast Layak Disimak
DISPONSORI
S
State Secrets: Inside The Making Of The Electric State


1 Family Secrets: Chris Pratt & Millie Bobby Brown Share Stories From Set 22:08
22:08
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai22:08
Host Francesca Amiker sits down with directors Joe and Anthony Russo, producer Angela Russo-Otstot, stars Millie Bobby Brown and Chris Pratt, and more to uncover how family was the key to building the emotional core of The Electric State . From the Russos’ own experiences growing up in a large Italian family to the film’s central relationship between Michelle and her robot brother Kid Cosmo, family relationships both on and off of the set were the key to bringing The Electric State to life. Listen to more from Netflix Podcasts . State Secrets: Inside the Making of The Electric State is produced by Netflix and Treefort Media.…
touchPODCAST
Tandai semua (belum/sudah) diputar ...
Manage series 3389426
Konten disediakan oleh touchpodcast. Semua konten podcast termasuk episode, grafik, dan deskripsi podcast diunggah dan disediakan langsung oleh touchpodcast atau mitra platform podcast mereka. Jika Anda yakin seseorang menggunakan karya berhak cipta Anda tanpa izin, Anda dapat mengikuti proses yang diuraikan di sini https://id.player.fm/legal.
Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updates Home of: - touchONCOLOGY - touchENDOCRINOLOGY - touchOPHTHALMOLOGY - touchNEUROLOGY - touchCARDIOLOGY - touchINFECTIOUSDISEASES - touchIMMUNOLOGY - touchRESPIRATORY - touchHAEMATOLOGY - touchDERMATOLOGY This information is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis, or treatment recommendations.
…
continue reading
102 episode
Tandai semua (belum/sudah) diputar ...
Manage series 3389426
Konten disediakan oleh touchpodcast. Semua konten podcast termasuk episode, grafik, dan deskripsi podcast diunggah dan disediakan langsung oleh touchpodcast atau mitra platform podcast mereka. Jika Anda yakin seseorang menggunakan karya berhak cipta Anda tanpa izin, Anda dapat mengikuti proses yang diuraikan di sini https://id.player.fm/legal.
Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updates Home of: - touchONCOLOGY - touchENDOCRINOLOGY - touchOPHTHALMOLOGY - touchNEUROLOGY - touchCARDIOLOGY - touchINFECTIOUSDISEASES - touchIMMUNOLOGY - touchRESPIRATORY - touchHAEMATOLOGY - touchDERMATOLOGY This information is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis, or treatment recommendations.
…
continue reading
102 episode
Alle episoder
×t
touchPODCAST

1 Tailoring treatment in myelofibrosis: Addressing anaemia and thrombocytopenia 35:35
35:35
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai35:35
touchPANEL DISCUSSION for touchHAEMATOLOGY Listen to three experts as they explore the burden of myelofibrosis and anaemia and/or thrombocytopenia, discuss targeted treatment strategies and how to maximize benefits for patients. The experts Prof. Haifa Kathrin Al-Ali – University Hospital of Halle, Halle (Saale), Germany Prof. Jean-Jacques Kiladjian – Université Paris Cité and Saint-Louis Hospital, Paris, France Prof. Alessandro Vannucchi – University of Florence, Florence, Italy This touchPODCAST is for HCPs outside of the UK and USA only. This activity is funded by an independent medical education grant from GSK. This activity is provided by touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: https://touchhaematologyime.org/…
t
touchPODCAST

1 Video 3: MDT perspectives on identifying and managing key ADC treatment toxicities in patients with metastatic breast cancer 11:54
11:54
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai11:54
Listen to key experts from a multidisciplinary team consider the strategies to avoid, mitigate, identify and effectively manage side effects associated with ADCs in patients with metastatic breast cancer. The multidisciplinary team Medical oncologist: Dr Véronique Diéras, Centre Eugène Marquis, Rennes, France Nurse practitioner: Dr Kayla Freeman, Emory Winship Cancer Institute, Atlanta, GA, USA Clinical oncology pharmacy specialist: Dr Scott Edwards, Dr. H. Bliss Murphy Cancer Center, St. John’s, Newfoundland, Canada This touchPODCAST is for HCPs outside of the UK only. This activity is funded by an independent medical education grant from Gilead Sciences, Inc. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: www.touchONCOLOGY.com…
t
touchPODCAST

1 Video 2: MDT perspectives on communicating ADC treatment toxicities to patients with metastatic breast cancer 13:03
13:03
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai13:03
Listen to key experts from a multidisciplinary team discuss effective strategies for communicating the potential side effects associated with ADC treatment to patients with metastatic breast cancer. The multidisciplinary team Medical oncologist: Dr Véronique Diéras, Centre Eugène Marquis, Rennes, France Nurse practitioner: Dr Kayla Freeman, Emory Winship Cancer Institute, Atlanta, GA, USA Patient advocate: Mrs Lesley Turner, Independent Cancer Patients’ Voice, UK This touchPODCAST is for HCPs outside of the UK only. This activity is funded by an independent medical education grant from Gilead Sciences, Inc. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: www.touchONCOLOGY.com…
t
touchPODCAST

1 Video 1: MDT perspectives on the safety profiles of current and emerging ADCs in metastatic breast cancer 11:59
11:59
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai11:59
Listen to key experts from a multidisciplinary team review and discuss the safety profiles of current and emerging ADCs in patients with metastatic breast cancer. The multidisciplinary team Medical oncologist: Dr Véronique Diéras, Centre Eugène Marquis, Rennes, France Nurse practitioner: Dr Kayla Freeman, Emory Winship Cancer Institute, Atlanta, GA, USA This touchPODCAST is for HCPs outside of the UK only. This activity is funded by an independent medical education grant from Gilead Sciences, Inc. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: www.touchONCOLOGY.com…
t
touchPODCAST

1 Precision in practice: Adopting emerging therapies for retinal diseases to reduce burden of disease 19:12
19:12
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai19:12
touchEXPERT FOCUS for touchOPHTHALMOLOGY Listen to retina specialist Prof. Peter Kaiser answer a series of questions on the current clinical landscape for neovascular age-related macular degeneration and diabetic macular oedema, share his perspective on how newly available treatments are influencing the existing standard of care and provide guidance on how new therapies can be effectively integrated into clinical practice. The expert Prof. Peter Kaiser, Cleveland Clinic Lerner College of Medicine, Cleveland, OH, USA This touchPODCAST is for HCPs outside of the USA and UK only. This activity is funded by an independent medical education grant from Bayer Consumer Care AG. The activity is provided by touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: https://touchophthalmologyime.org/adopting-emerging-therapies-for-retinal-diseases…
t
touchPODCAST

1 Expanding horizons for patients with Pompe disease: Using data to guide clinical practice 1:06:26
1:06:26
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai1:06:26
touchCONGRESS for touchCARDIO Listen to world-leading expert Prof. Tahseen Mozaffar as he reviews key data on current and emerging treatment options for Pompe disease presented at the 29th Annual Congress of the World Muscle Society, and 21st Annual WORLDSymposium 2025. Prof. Mozaffar is then joined by fellow experts Dr Jennifer L Cohen and Prof. Benedikt Schoser to discuss how these data may apply in clinical practice. Overview Data reviews with Prof. Mozaffar, Expert panel discussions with Prof. Mozaffar, Dr Cohen and Prof. Schoser on the themes below Clinical themes Clinical and real-world data on long-term outcomes in Pompe disease Outcomes and impact of treatment switching in Pompe disease Latest clinical data on current and emerging therapies in Pompe disease The internationally renowned Pompe disease expert faculty Prof. Tahseen Mozaffar, Irvine, CA, USA Dr Jennifer L Cohen, Durham, NC, USA Prof. Benedikt Schoser, Munich, German This touchPODCAST is for HCPs outside of the UK only. This activity is funded by an independent medical education grant from Amicus Therapeutics. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website:…
t
touchPODCAST

1 Expanding horizons for patients with Pompe disease: Using data to guide clinical practice 1:06:27
1:06:27
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai1:06:27
touchCONGRESS for touchENDOCRINOLOGY Listen to world-leading expert Prof. Tahseen Mozaffar as he reviews key data on current and emerging treatment options for Pompe disease presented at the 29th Annual Congress of the World Muscle Society, and 21st Annual WORLDSymposium 2025. Prof. Mozaffar is then joined by fellow experts Dr Jennifer L Cohen and Prof. Benedikt Schoser to discuss how these data may apply in clinical practice. Overview Data reviews with Prof. Mozaffar, Expert panel discussions with Prof. Mozaffar, Dr Cohen and Prof. Schoser on the themes below Clinical themes Clinical and real-world data on long-term outcomes in Pompe disease Outcomes and impact of treatment switching in Pompe disease Latest clinical data on current and emerging therapies in Pompe disease The internationally renowned Pompe disease expert faculty Prof. Tahseen Mozaffar, Irvine, CA, USA Dr Jennifer L Cohen, Durham, NC, USA Prof. Benedikt Schoser, Munich, Germany This touchPODCAST is for HCPs outside of the UK only. This activity is funded by an independent medical education grant from Amicus Therapeutics. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website:…
t
touchPODCAST

1 Expanding horizons for patients with Pompe disease: Using data to guide clinical practice 1:06:26
1:06:26
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai1:06:26
touchCONGRESS for touchNEUROLOGY Listen to world-leading expert Prof. Tahseen Mozaffar as he reviews key data on current and emerging treatment options for Pompe disease presented at the 29th Annual Congress of the World Muscle Society, and 21st Annual WORLDSymposium 2025. Prof. Mozaffar is then joined by fellow experts Dr Jennifer L Cohen and Prof. Benedikt Schoser to discuss how these data may apply in clinical practice. Overview Data reviews with Prof. Mozaffar, Expert panel discussions with Prof. Mozaffar, Dr Cohen and Prof. Schoser on the themes below Clinical themes Clinical and real-world data on long-term outcomes in Pompe disease Outcomes and impact of treatment switching in Pompe disease Latest clinical data on current and emerging therapies in Pompe disease The internationally renowned Pompe disease expert faculty Prof. Tahseen Mozaffar, Irvine, CA, USA Dr Jennifer L Cohen, Durham, NC, USA Prof. Benedikt Schoser, Munich, Germany This touchPODCAST is for HCPs outside of the UK only. This activity is funded by an independent medical education grant from Amicus Therapeutics. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website:…
t
touchPODCAST

1 Expanding horizons for patients with Pompe disease Using data to guide clinical practice 1:06:27
1:06:27
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai1:06:27
touchCONGRESS for touchRESPIRATORY Listen to world-leading expert Prof. Tahseen Mozaffar as he reviews key data on current and emerging treatment options for Pompe disease presented at the 29th Annual Congress of the World Muscle Society, and 21st Annual WORLDSymposium 2025. Prof. Mozaffar is then joined by fellow experts Dr Jennifer L Cohen and Prof. Benedikt Schoser to discuss how these data may apply in clinical practice. Overview Data reviews with Prof. Mozaffar, Expert panel discussions with Prof. Mozaffar, Dr Cohen and Prof. Schoser on the themes below Clinical themes Clinical and real-world data on long-term outcomes in Pompe disease Outcomes and impact of treatment switching in Pompe disease Latest clinical data on current and emerging therapies in Pompe disease The internationally renowned Pompe disease expert faculty Prof. Tahseen Mozaffar, Irvine, CA, USA Dr Jennifer L Cohen, Durham, NC, USA Prof. Benedikt Schoser, Munich, Germany This touchPODCAST is for HCPs outside of the UK only. This activity is funded by an independent medical education grant from Amicus Therapeutics. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website:…
t
touchPODCAST

1 MDT perspectives on the importance of patient engagement in PARPi use - Video 3 13:21
13:21
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai13:21
touchMDT for touchONCOLOGY Listen to experts Dr Alicia Morgans, Dr Grace Cullen, and patient advocate, Mr Tony Collier, discuss the importance and practicalities of engaging patients in their care and hear insights from the perspective of a patient advocate in relation to the use of PARP inhibitors. The multidisciplinary team and patient advocate: Medical oncologist – Dr Alicia Morgans Dana-Farber Cancer Institute, Boston, Massachusetts, USA Nurse practitioner – Dr Grace Cullen John D. Dingell VA Medical Center, Detroit, Michigan, USA Patient Advocate – Mr Tony Collier Tackle Prostate Cancer, London, UK This touchPODCAST is for HCPs outside of the UK only. This activity is supported by an independent medical education funding request from AstraZeneca. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: https://touchoncologyime.org/mdt-parp-inhibitors-in-mcrpc/…
t
touchPODCAST

1 MDT perspectives on understanding precision medicine to guide PARPi use in mCRPC - Video 2 13:45
13:45
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai13:45
touchMDT for touchONCOLOGY Somatic and germline testing are key in managing metastatic castration-resistant prostate cancer (mCRPC). Listen as Prof. Albrecht Stenzinger shares his perspectives as a pathologist with Dr Alicia Morgan and Dr Grace Cullen. The multidisciplinary team: Medical oncologist – Dr Alicia Morgans Dana-Farber Cancer Institute, Boston, Massachusetts, USA Nurse practitioner – Dr Grace Cullen John D. Dingell VA Medical Center, Detroit, Michigan, USA Pathologist – Prof. Albrecht Stenzinger University of Heidelberg, Heidelberg, Germany This touchPODCAST is for HCPs outside of the UK only. This activity is supported by an independent medical education funding request from AstraZeneca. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: https://touchoncologyime.org/mdt-parp-inhibitors-in-mcrpc/…
t
touchPODCAST

1 MDT perspectives on unlocking the data on PARPi to support shared decision-making in mCRPC - Video 1 13:44
13:44
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai13:44
touchMDT for touchONCOLOGY MDT perspectives on unlocking the data on PARPi to support shared decision-making in mCRPC Experts Dr Alicia Morgans and Dr Grace Cullen share insights into using evidence to guide practice and shared decision-making with patients with metastatic castration-resistant prostate cancer (mCRPC). The multidisciplinary team: Medical oncologist – Dr Alicia Morgans Dana-Farber Cancer Institute, Boston, Massachusetts, USA Nurse practitioner – Dr Grace Cullen John D. Dingell VA Medical Center, Detroit, Michigan, USA This touchPODCAST is for HCPs outside of the UK only. This activity is supported by an independent medical education funding request from AstraZeneca. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: https://touchoncologyime.org/mdt-parp-inhibitors-in-mcrpc/…
t
touchPODCAST

1 The next frontier in managing obesity and T2D: The role of novel combinations for touchENDOCRINOLOGY 32:02
32:02
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai32:02
touchEXPERT OPINIONS for touchENDOCRINOLOGY Listen to three experts discuss the rationale behind glucagon-like peptide-1 (GLP-1)-based combination therapies and review the latest clinical evidence for these novel combinations. The expert faculty will provide their insights on what these combination treatments may mean for the future management of obesity with or without type 2 diabetes (T2D). The experts Dr Sue Pedersen, University of Calgary, Calgary, Canada Prof. Carel le Roux, University College Dublin, Dublin, Ireland Dr Donna Ryan, Pennington Biomedical Research Center, Baton Rouge, LA, USA This touchPODCAST is for healthcare professionals outside of the USA and UK. This activity is funded by an independent medical education grant from Novo Nordisk A/S. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: www.touchENDOCRINOLOGY.com…
t
touchPODCAST

1 The next frontier in managing obesity and T2D: The role of novel combinations for touchCARDIO 32:01
32:01
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai32:01
touchEXPERT OPINIONS for touchCARDIO Listen to three experts discuss the rationale behind glucagon-like peptide-1 (GLP-1)-based combination therapies and review the latest clinical evidence for these novel combinations. The expert faculty will provide their insights on what these combination treatments may mean for the future management of obesity with or without type 2 diabetes (T2D). The experts Dr Sue Pedersen, University of Calgary, Calgary, Canada Prof. Carel le Roux, University College Dublin, Dublin, Ireland Dr Donna Ryan, Pennington Biomedical Research Center, Baton Rouge, LA, USA This touchPODCAST is for healthcare professionals outside of the USA and UK. This activity is funded by an independent medical education grant from Novo Nordisk A/S. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: www.touchCARDIO.com…
t
touchPODCAST

1 From clinical trials to clinical practice: Applying CDK4/6 inhibitors in HR+/HER2– early breast cancer 36:50
36:50
Putar Nanti
Putar Nanti
Daftar
Suka
Menyukai36:50
touchEXPERT OPINIONS for touchONCOLOGY Listen to three experts in breast cancer as they provide insights into the current guideline recommendations for the use of targeted therapy in patients with HR+/HER2– early breast cancer, evaluate the latest data for CDK4/6 inhibitors in this patient population and consider how to maximize the potential of these agents through risk stratification and safety considerations. The experts Prof. Carlos Barrios: Latin American Cooperative Oncology Group (LACOG), Porto Alegre, Brazil Prof. Dr. med. Peter Fasching: University Hospital Erlangen and Comprehensive Cancer Center, Erlangen-EMN, Germany Dr Sonia Pernas: Catalan Institute of Oncology-Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain This touchPODCAST is for healthcare professionals outside of the UK and the USA. This activity is funded by an independent medical education grant from Novartis. This activity is provided by touchIME. For further information visit our website: www.touchONCOLOGY.com…
Selamat datang di Player FM!
Player FM memindai web untuk mencari podcast berkualitas tinggi untuk Anda nikmati saat ini. Ini adalah aplikasi podcast terbaik dan bekerja untuk Android, iPhone, dan web. Daftar untuk menyinkronkan langganan di seluruh perangkat.